The Trump administration began mass layoffs of 10,000 staffers at US health agencies yesterday, according to multiple sources, with security guards barring entry to some employees just hours after ...

The FDA approved several therapies in oncology in the month of March 2025. These drugs included treatments for ...

The Independent Data Monitoring Committee (IDMC) has recommended to continue study as planned as there are no safety concerns seen in the data ...

COCP READ THE FULL COCP RESEARCH REPORT Business Update Update on CDI-988 On January 8, 2025, Cocrystal Pharma, Inc.

Biosimilars offer affordable medical treatments, but regulatory guidelines need updating to ensure safety, efficacy, and ...

Novo Nordisk's Phase 3b STRIDE trial shows Ozempic improves walking distance in peripheral artery disease, while the SOUL ...

Drug abuse continues to grow exponentially. The U.S. alone pours billions of dollars into this never-ending war and has a ...

Although itolizumab did not improve response rates at Day 29 for patients with acute GVHD, the therapy showed significant ...

High-profile attorney Billy Gibbens confirmed to WDSU that he is now representing Bogalusa Mayor Tyrin Truongin in the case.

Looking ahead, Leen Kawas believes that the successful integration of AI into drug discovery will require thoughtful ...

The first patient was dosed in a phase 3 trial of IBI354 for platinum-resistant ovarian cancer with HER2 expression.

Researchers from the Drug Safety Research Unit are calling for the robust monitoring ... The researchers say: “The post-authorisation monitoring of the complex benefit-risk profile of lecanemab in ...